Your browser doesn't support javascript.
loading
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe gastrointestinal and hepatic toxicities from checkpoint inhibitors.
Dougan, Michael; Blidner, Ada G; Choi, Jennifer; Cooksley, Tim; Glezerman, Ilya; Ginex, Pamela; Girotra, Monica; Gupta, Dipti; Johnson, Douglas; Shannon, Vickie R; Suarez-Almazor, Maria; Anderson, Ronald; Rapoport, Bernardo L.
  • Dougan M; Massachusetts General Hospital, Boston, MA, USA.
  • Blidner AG; Harvard Medical School, Boston, MA, USA.
  • Choi J; Laboratory of Immunopathology, Institute of Biology and Experimental Medicine-CONICET, Buenos Aires, Argentina.
  • Cooksley T; Division of Oncodermatology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Glezerman I; Tim Cooksley, Manchester University Foundation Trust, Manchester, UK.
  • Ginex P; The Christie, University of Manchester, Manchester, UK.
  • Girotra M; Renal Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
  • Gupta D; Oncology Nursing Society, Pittsburgh, PA, USA.
  • Johnson D; Endocrine Division, Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
  • Shannon VR; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
  • Suarez-Almazor M; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
  • Anderson R; Department of Medicine, Vanderbilt University Medical Center and Vanderbilt Ingram Cancer Center, Nashville, TN, USA.
  • Rapoport BL; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Support Care Cancer ; 28(12): 6129-6143, 2020 Dec.
Article en En | MEDLINE | ID: mdl-32856210
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad Hepática Inducida por Sustancias y Drogas / Enfermedades Gastrointestinales / Inhibidores de Puntos de Control Inmunológico / Inmunoterapia / Neoplasias Tipo de estudio: Guideline / Qualitative_research / Risk_factors_studies Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad Hepática Inducida por Sustancias y Drogas / Enfermedades Gastrointestinales / Inhibidores de Puntos de Control Inmunológico / Inmunoterapia / Neoplasias Tipo de estudio: Guideline / Qualitative_research / Risk_factors_studies Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article